Here the authors generate a measles virus-based vaccine expressing SARSCoV-2 spike protein and show immunogenicity and protection in mice and hamsters, including neutralization of circulating variants of concerns in vitro.
- Phanramphoei N. Frantz
- Aleksandr Barinov
- Frédéric Tangy